Skip to content
Search

Latest Stories

Nearly 70 per cent doctors prefer c-section: Study

Majority of doctors in the UK choose c-section over vaginal birth due to fear of litigation, reveals a new study.

According to a research by Trinity College Dublin, 70 per cent of doctors may do so because they are afraid of being sued and to avoid damage to the woman’s body. The unavailability of staff members to assist in vaginal birth is another important reason for opting c-section, the study cited by Mail Online revealed.


This is despite evidence suggesting that vaginal births are safer. Typically, a c-section is carried out only if it is safer for both the mother and baby than a vaginal birth.

The study analysed 34 scientific studies, involving 9,008 midwives and obstetricians between 1992 and 2016, about doctors' attitudes to c-sections. About 67 per cent of obstetricians in the UK and Ireland choose c-section due to fear of legal consequences following complications during normal delivery.

 The ability to control labour was also something that appealed to doctors, who otherwise would have had to sometimes wait through the day for a natural birth.

“Caesarean section rates are increasing worldwide, particularly among first-time mothers, with limited explanation of the factors that influence the rising trend,” the study’s author, PHD student Sunita Panda, told the publication.

“This is a big concern for health care professionals because vaginal birth is safer and associated with fewer complications. Our research gives important insight into the 'why' behind the rising rate of caesarean sections.

 “Our study identified the significant influence of fear of litigation on clinicians' decision to perform caesarean sections, irrespective of hospital setting, age, gender, professional experience, resources and culture within the health care system.”

The findings of the study were published in the journal PLOS ONE.

More For You

Camellia Panjabi's cookbook elevates
vegetables from sides to stars

Camellia Panjabi (Photo: Ursula Sierek)

Camellia Panjabi's cookbook elevates vegetables from sides to stars

RESTAURATEUR and writer Camellia Panjabi puts the spotlight on vegetables in her new book, as she said they were never given the status of a “hero” in the way fish, chicken or prawns are.

Panjabi’s Vegetables: The Indian Way features more than 120 recipes, with notes on nutrition, Ayurvedic insights and cooking methods that support digestion.

Keep ReadingShow less
Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
HH Guruji performed the Dhwaja Ritual at Ambaji Temple

HH Guruji performed the Dhwaja Ritual at Ambaji Temple

Mahesh Liloriya

The holy town of Ambaji witnessed a spiritually significant day on Sunday as His Holiness Siri Rajrajeshwar Guruji, head of the International Siddhashram Shakti Centre, London, performed the Dhwaja ritual at the historic Ambaji Temple in Gujarat, one of the most revered Shakti Peeths of India.

Keep ReadingShow less
Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Mahesh Liloriya

The International Siddhashram Shakti Centre in Harrow witnessed an inspiring and environmentally responsible celebration of Ganesh Utsav 2025, which concluded on Saturday, 6 September, with the Ganesh Visarjan ritual performed on the sacred occasion of Anant Chaturdashi.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less